L11- GI Infections IV (non-inflam. diarrhea, viral) Flashcards

1
Q

Rotavirus:

  • (1) family
  • (2) genome
  • (3) size, shape
  • (4) relevant genotypes
  • requires (large/small) inoculation dose
A

1- reoviridae (REO = respiratory enteric orphan)
2- 11 segments dsRNA, non-enveloped
3- wheel-shape, double capsid, 70nm diameter
4- G1, G2, G3, G4
5- small (~100 particles)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Rotavirus:

  • serogroups are based on (1) Ag
  • attachment is controlled by (2) Ag
  • these proteins are also important to (3) in terms of incidences
A

1- VP7, G Ag = glycoprotein

2- VP4, P Ag = protease

3- defining serotype and therefore vaccine development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

(1) rotavirus is the most common cause of infantile gastroenteritis in USA, its (2) in china, usually in (3) age group. It adults, they present with (4) symptoms.
(5) Briefly describe the other serogroups.

A

1- group A
2- group B (+ pigs)
3- (6 mos to) <2 y/o [immunity by 4-5y/o]
4- milder diarrhea

5- C found worldwide, D/E/F not found in humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

serotyping in rotavirus mainly refers to….

A

group A (USA strain) rotavirus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe rotavirus preferred season by location

A

Temperate // High Income: mainly winter, spring

Tropical // Low Income: year round

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Rotavirus pathogenesis:

  • (1) transmission
  • (2) incubation period
  • (3) sxs
A

1- fecal-oral, water-borne
2- <48 hrs / 1-3 days
3- watery diarrhea for 3-8 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Rotavirus pathogenesis:

  • (1) location of replication –> causes (2) structural changes in those areas
  • (3) is the main physiological effect
  • viral shedding via lasts (4)
A

1- villous epithelium in SI
2- columnar epithelium replaced by irregular cuboidal, crypt-like cells
3- multiple defects in fluid and electrolyte regulation (in affected intestinal mucosa)
4- 10 days, peaks at day 8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

briefly describe rotavirus pathogenesis

A

1) ingestion
2) infects epithelial cells (VP4, P, protease Ag) of SI
3) shortening / atrophy of villi of SI
4) dec production of brush border digestive enzymes, e.g. disaccharidases
5) watery diarrhea, help from NSP4 protein acting as toxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

______ part of rotavirus acts in a toxin-like manner to inc net fluid excretion

A

NSP4 protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Rotavirus Dx

A

Stool (peak day 3-4):

  • latex agglutination
  • EIA for characterization (enzyme immunoassays)
  • electron microscopy (labor intensive, insensitive)
  • electrophoresis of RNA segments
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

______ are at biggest risk of getting rotavirus gastroenteritis, especially in outbreaks

A
  • young children (daycare adults)

- adults in congregrate living centers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Norovirus:

  • (1) family
  • (2) genome
  • (3) shape, size
  • (4) transmission
A

1- calciviridae

2- (+) ssRNA, non-enveloped

3- icosahedral nucleocapsid, small 27nm diameter

4- many: food, water, people, manufacturing, environment contamination, animals, shellfish

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Norovirus:

  • (1) predominant location
  • (2) affected age group
  • requires a (large/small) inoculation dose
  • (4) predominant season
A

1- worldwide

2- older children, adults (not children <5y/o)

3- very small, 18 particles

4- winter (aka, winter vomiting disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

brief pathogenesis of Norovirus

A

1) ingestion –> multiplication in SI
2) transient lesions of mucosa (microvilli shortened + widened intercellular spaces are noted on EM)
3) no colon involvement = NO fecal leukocytes
4) shed in feces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Diagnosis criteria of epidemiological Norovirus gastroenteritis

A

1) mean/median illness duration of 12-60hrs
2) mean/median incubation 24-48hrs
3) >50% patients with vomiting
4) Sxs last 48-72hrs, rapid recovery
5) no bacterial agent previously found

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe Norovirus infection clinical diagnosis

A

(not routinely screened) Virus is found in stool (peak day 2 out 5):

  • difficult to culture
  • RT-qPCR (highly sensitive), RT-PCR (genotyping), EIA (not sensitive)
17
Q

(T/F) for the following statements:

  • (1) rotovirus has a vaccine
  • (2) norovirus has a vaccine
A

1- T (childhood)

2- F, in clinical trials

18
Q

Astrovirus:

  • (1) family
  • (2) genome
  • (3) shape, size
A

1- astroviridae
2- non-enveloped, (+) ssRNA
3- small, 27-30nm diameter, icosahedral symetry, smooth/slightly indented outer shell

19
Q

Astrovirus:

  • mostly infects (1) age group
  • (2) peak season
  • resembles (3), so (4) assumption is made
A

1- infants
2- winter (some throughout)
3- rotavirus (but milder)
4- assume rotavirus infection unless vaccination status in known (or viral nuclear make-up is known)

20
Q

Astrovirus pathogenesis:

  • (1) architectural changes in (2) segment
  • end result of decreased (3) secretion
  • (4) is the resulting symptom
A

1- small intestinal villus shortening
2- SI
3- intestinal brush border enzymes
4- osmotic diarrhea

21
Q

Adenovirus:

  • (1) family
  • (2) genome
  • (3) shape, size
  • (4) main infectious serotype
A

1- adenoviridae
2- dsDNA (protein core)
3- small 70-100nm diameter, icosahedral protein shell
4- 40-42 of group F

22
Q

Adenovirus pathogenesis:

  • (1) main target tissue
  • (2) secondary target tissues
  • may replicate in (3)
  • (4) main GI symptoms
A

1- respiratory tract
2- epithelial cells in pharynx, conjunctiva, SI (occasionally others)
3- intestines –> present in stool
4- diarrhea, w/ or w/o vomiting

23
Q

Cryptosporidium spp.:

  • (1) affecting species
  • (2) location
  • (3) common transmission
A

1- parasite: C. parvum, C. hominis

2- worldwide

3- contaminated water (drinking or recreational) OR person-to-person

24
Q

Cryptosporidium spp.:

  • (1) typical presentation
  • (2) presentation in endemic countries described as (3)
  • (4) common in presentation in at-risk populations
A

1- Self-limiting diarrhea: stomach cramps / pain, dehydration, n/v, fever, weight loss

2- persistent diarrhea in children
3- developing tropical, sub-tropical countries

4- chronic diarrhea in immuno-compromised patients (AIDS- CD4 count <100 per uL)

25
Q

Cryptosporidium spp.:

  • (1) unique feature in terms of spread
  • requires (large/small) dose
  • mostly affects (3) populations
A

1- oocysts are infectious, last in environment up to 1 yr due to disinfecant / chlorination resistance

2- low dose (water sources)

3- immuno-compromised (weak against immune system): AIDS, children

26
Q

Cryptosporium spp. lifecycle:

  • (1- include types) form excreted in feces
  • after ingestion –> attachment to (2)
  • within (2), conversion to (3)
  • (4) will recur to release (5) which eventually progress to (6) and then (7)
  • Note- (7) reforms (1)
A

1- *Oocysts: thick-walled (commonly excreted) OR thin-walled (autoinfection)
2- brush border epithelium
3- (parasitophorous vacuole –>) enlarges into *Trophozoites
4- asexual multiplication
5- type I meronts / motile merozoites
6- sexual multiplication / type II meronts / micro-/macro-gamonts
7- (microgamete + macrogamere ==>) *zygote –> oocysts

27
Q

Cryptosporidium spp. Dx

A

(not routine)
-stool microscopic investigation: multple, wet mounts, thick walled oocysts

  • Differential stain: modified Ziehl-Neelson
  • Immunofluorescent assay
  • Ag-detection assays